Last Friday on our weekly MedHeads broadcast, we had a discussion about investment trends in digital health, current obstacles and what current startups should be conscious of going in.
Our own Neil Versel moderated, and Dr. Dan Peterson, founder of Teqqa, which is focused on improving the treatment of infectious diseases and addressing the growing problem of antibiotic resistance, joined the conversation along with Lucas Felt, president of The Medical Memory, which developed a way to record and share physician visits, and Steve Kraus, a partner with Bessemer Venture Partners.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Kraus touched on the fact that the start of this year, when it comes to early-stage companies in the public market, it’s been really rough, which can be attributed to the current state of the stock market.
But when it comes to early digital health, he says, “We’re very much in the first couple innings of what I think of as a nine-inning ballgame. There’s been massive disruption within the healthcare economy, and it’s really driven by regulations.” He added, though, that there are massive opportunities in digital health underway currently with companies that have just gone public, so there should be optimism for investors and entrepreneurs despite current stock trends.
Peterson voiced that as an entrepreneur in the current market, they are careful about who invests in the company, but overall things look good for Teqqa. Felt expressed they The Medical Memory is not cash positive currently, they are currently looking for more investors, but thus far they have realized based on feedback that the demand for their product and further development is extremely worthwhile.
Overall 2016 looks like a year of potential obstacles equally matched with big potential. We’ll see how it plays out.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Both Teqqa and The Medical Memory will be taking part in the StartUp Showcase at MedCity INVEST April 12 and 13.
To hear insights from the entire discussion, watch the MedHeads broadcast below.
